Document Detail


ACR-ASTRO Practice Guideline for the Performance of Therapy With Unsealed Radiopharmaceutical Sources.
MedLine Citation:
PMID:  21716005     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
This guideline is intended to guide appropriately trained and licensed physicians performing therapy with unsealed radiopharmaceutical sources. Adherence to this guideline should help to maximize the efficacious use of these procedures, maintain safe conditions, and ensure compliance with applicable regulations. The topics dealt with in this guideline include indications for the use of iodine-131, both for the treatment of hyperthyroidism and thyroid carcinoma. In addition, indications for other less common procedures include those for the use of phosphorous-32 in its liquid and colloidal forms, strontium-89, samarium-153, and the use of Y-90 antibodies.
Authors:
Robert E Henkin; John D Del Rowe; Perry W Grigsby; Alan C Hartford; Hossein Jadvar; Roger M Macklis; J Anthony Parker; Jeffrey Y C Wong; Seth A Rosenthal
Related Documents :
17635485 - Review of new regulations for the conduct of clinical trials of investigational medicin...
10160935 - A future for clinical management.
1260615 - Management of "psychosomatic" problems in clinical practice.
22224155 - In-training practice patterns of combined emergency medicine/internal medicine resident...
21375745 - A trial on unruptured intracranial aneurysms (the team trial): results, lessons from a ...
14570525 - Trust in management as a buffer of the relationships between overload and strain.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Clinical nuclear medicine     Volume:  36     ISSN:  1536-0229     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-6-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7611109     Medline TA:  Clin Nucl Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  e72-e80     Citation Subset:  -    
Affiliation:
From the *Department of Nuclear Medicine, Loyola University Medical Center, Maywood, IL; †Department of Radiation Oncology, North Shore University Hospital, Manhasset, NY; ‡Department of Radiation Oncology, Washington University Medical Center, St. Louis, MO; §Section of Radiation Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH; ¶Department of Radiology, University of Southern California, Los Angeles, CA; ∥Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH; **Department of Nuclear Medicine, Beth Israel Deaconess Medical Center, Boston, MA; ††Department of Radiation Oncology and Radiation Research, City of Hope Medical Center, Duarte, CA; and ‡‡Radiation Oncology Centers, Radiological Association of Sacramento, Sacramento, CA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reversal of drug-induced rhabdomyolysis on bone scan.
Next Document:  FDG PET/CT in Evaluation of Pyrexia of Unknown Origin.